Status:
COMPLETED
Psychiatric Disturbances and COVID-19 Infection
Lead Sponsor:
Cairo University
Collaborating Sponsors:
Ministry of Health and Population, Egypt
National Hepatology & Tropical Medicine Research Institute
Conditions:
Corona Virus Infection
Eligibility:
All Genders
18+ years
Brief Summary
This observational study aims at Assessment of the prevalence and types Psychiatric disturbances that affects patients with COVID-19 infection with and without previous psychiatric diseases. in additi...
Detailed Description
International outbreak of the novel coronavirus (2019- nCoV) raised intense attention of specialists worldwide, including psychiatrists. The five stages of shock-denial, anger, bargaining, depression,...
Eligibility Criteria
Inclusion
- Confirmed cases with COVID-19 defined as a positive result to real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) assay for nasal and pharyngeal swab specimens
Exclusion
- Patients who refuse to be included in the research
Key Trial Info
Start Date :
June 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04459403
Start Date
June 8 2020
End Date
December 30 2020
Last Update
January 28 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
15 Mayo Smart Hospital
Cairo, Egypt
2
National hepatology and tropical medicine research institute
Cairo, Egypt
3
Students hospital
Giza, Egypt